Cargando…
The Long-Term and Short-Term Efficacy of Immunotherapy in Non-Small Cell Lung Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis
BACKGROUND: Although immunotherapy has been widely used, there is currently no research comparing immunotherapy for non-small cell lung cancer (NSCLC) patients with brain metastases (BMs). This meta-analysis addresses a gap in the comparison of immunotherapy efficacy, including immune checkpoint inh...
Autores principales: | Chu, Xianjing, Niu, Lishui, Xiao, Gang, Peng, Haiqin, Deng, Fuxing, Liu, Zhiyuan, Wu, Honghua, Yang, Lei, Tan, Zhuguilong, Li, Zhanzhan, Zhou, Rongrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175180/ https://www.ncbi.nlm.nih.gov/pubmed/35693805 http://dx.doi.org/10.3389/fimmu.2022.875488 |
Ejemplares similares
-
Cost-effectiveness of neoadjuvant pembrolizumab plus chemotherapy with adjuvant pembrolizumab for early-stage non-small cell lung cancer in the United States
por: Tian, Wentao, et al.
Publicado: (2023) -
Case report: Brain metastasis necrosis with immune checkpoint inhibitors plus chemotherapy for advanced non-small cell lung cancer
por: Niu, Lishui, et al.
Publicado: (2022) -
Editorial: Predictive short/long-term efficacy biomarkers and resistance mechanisms of CAR-T immunotherapy treatment
por: Cheng, Jiali, et al.
Publicado: (2023) -
Radiomics and deep learning models to differentiate lung adenosquamous carcinoma: A multicenter trial
por: Chu, Xianjing, et al.
Publicado: (2023) -
Clinical value of a plasma Epstein–Barr virus DNA assay in the diagnosis of recurrent or metastatic nasopharyngeal carcinoma: a meta-analysis
por: Peng, Haiqin, et al.
Publicado: (2019)